Work

Bevacizumab (Bev) alone or in combination with TRC105 for metastatic renal cell cancer (mRCC): A California Cancer Consortium clinical trial.

Year: 2015

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2015.33.15_suppl.4542

Authors: Tanya B. Dorff, Jeff Longmate, Sumanta Kumar Pal, Walter Michael Stadler, Mayer N. Fishman, Ulka N. Vaishampayan, Amol Rajeev Rao, James Hu, David I. Quinn, Primo Lara

Institutions: USC Norris Comprehensive Cancer Center, City Of Hope National Medical Center, City of Hope, University of Chicago, Moffitt Cancer Center, Wayne State University, The Barbara Ann Karmanos Cancer Institute, University of Southern California, UC Davis Comprehensive Cancer Center

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2604354645

Cites:

Cited by: 1

Related to: 10